New research in Radiology suggests thermal ablation is a safe, effective primary treatment for stage 1 non-small cell lung cancer for individuals who cannot undergo lung cancer surgery because of age or health status. Researchers have also noted it is non-inferior to stereotactic radiation therapy.

The 2018 International Day of Radiology (IDoR) will focus exclusively on cardiac imaging. Like previous years, IDoR 2018 will be celebrated on Nov. 8—the date Wilhelm Conrad Roentgen, the “father of diagnostic radiology,” discovered the existence of x-rays in 1895.

Many academic medical centers are shifting away from using radiology residents for after-hours imaging interpretations and turning to overnight attending radiologists instead, according to a new analysis published in Radiology.

Finance is a language. But even more to the point for radiologists—or, at least, the ones who wish to help future-proof their practices and, along the way, advance the profession as a whole—it’s the language of leadership.

Qure.ai, a San Mateo, California-based healthcare startup focused on artificial intelligence (AI), has released the results of a thorough validation study confirming the accuracy of its deep learning chest x-ray algorithm. The study involved 1.2 million x-rays and their corresponding radiology reports.

Case Western Reserve University (CWRU) School of Medicine received a $1.1 million grant from the National Institutes of Health (NIH) to develop and evaluate imaging methods to diagnose peripheral arterial disease (PAD) that do not rely on gadolinium.

The adoption of PACS technology has been incredibly important for radiology, according to a new study published in the Journal of Digital Imaging, helping the specialty become largely filmless while improving workflow, efficiency and productivity. However, the authors noted, this current generation of PACS has numerous limitations.

The International Contrast Ultrasound Society (ICUS) submitted a citizen petition to the FDA asking the agency to eliminate boxed warnings from ultrasound contrast agents (UCAs) because data and clinical experience show they are unnecessary.

Using artificial intelligence, researchers at the NYU School of Medicine can correctly distinguish between two different types of lung tumors—adenocarcinoma and squamous cell carcinoma—with 97 percent accuracy.

NorthStar Medical Technologies, the Beloit, Wisconsin-based parent company of NorthStar Medical Radioisotopes, has appointed Stephen Merrick as president and CEO. Merrick was first hired in 2016 as the company’s senior vice president and chief operating officer.